ebook Munafa Stock Market Course + Intraday & FNO calls  

       

506235 announcements Alembic Ltd. announcements and dividends declared BSE

Alembic Ltd. Complete list of announcements declared & dividend announcements by Alembic Ltd. 506235

Alembic Ltd. 506235 listed on BSE and deals in

Announcements and dividends declared by Alembic Ltd. 506235

Alembic Pharma clears USFDA inspection at Vadodara bioequivalence facility with nil observations
Alembic Pharmaceuticals has reported that its Vadodara facility passed the recent inspection by the United States Food and Drug Administration with flying colors. Conducted from August 31 to September 10, 2026, the inspection resulted in zero observations,
Announcement as on 11 September 2026

Alembic Pharma clears USFDA inspection at Vadodara bioequivalence facility
Alembic Pharmaceuticals on Friday said the US health regulator has completed an unannounced inspection at its bioequivalence facility in Vadodara, Gujarat, with zero observation. In a regulatory filing, the company said the United States Food and Drug Admi
Announcement as on 11 September 2026

Alembic Pharma gets USFDA approval for generic chronic constipation treatment tablets
Alembic Pharmaceuticals announced USFDA approval for its generic prucalopride tablets. The company received final approval for strengths of one and two milligrams. These tablets are indicated for treating chronic idiopathic constipation in adults. The a
Announcement as on 28 July 2026

Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gel
Alembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval, for the 5% strength, means the company can now market its version, which is therapeutically equivalent to Almirall's
Announcement as on 29 June 2026

Alembic Pharma gets tentative nod from USFDA for generic cancer drug
Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step for the company in the cancer treatment drug market. The approval is for the 45mg strength, with potential for marketin
Announcement as on 19 June 2026

Announcements by Alembic Ltd. first page | Next page |

506235 Alembic Ltd. current price & indicator signals

Moving Averages for Alembic Ltd.

  • 5Day Average: 87.26
  • 12Day Average: 91.06
  • 20Day Average: 96.29
  • 50Day Average: 98.36
  • 100Day Average: 93.7
  • 150Day Average: 91.34
  • 200Day Average: 91.99

506235 Indicators & signals

Indicator MACD (12,26,9)

91.12, 95.01, -2.77
Indicator MACD is in negative zone

Indicator ADX (14)

40.43, 13.69, 32.27
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 44
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 506235 Alembic Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Fri Oct 2026 87.20 86.85 to 89.50 -2.52% 0.4 times
29 Thu Oct 2026 89.45 86.70 to 89.60 2.11% 0.56 times
28 Wed Oct 2026 87.60 86.55 to 88.00 0.4% 0.63 times
27 Tue Oct 2026 87.25 84.50 to 88.05 2.89% 0.75 times
26 Mon Oct 2026 84.80 83.75 to 86.90 -2.36% 1.06 times
23 Fri Oct 2026 86.85 86.20 to 90.70 -3.87% 1.68 times
22 Thu Oct 2026 90.35 90.05 to 93.30 -1.79% 0.42 times
21 Wed Oct 2026 92.00 91.45 to 96.30 -3.31% 0.94 times
19 Mon Oct 2026 95.15 94.80 to 98.25 -2.26% 0.94 times
16 Fri Oct 2026 97.35 94.60 to 98.10 1.09% 1.6 times
15 Thu Oct 2026 96.30 93.95 to 99.95 -2.18% 1.41 times
14 Wed Oct 2026 98.45 97.65 to 99.40 0.2% 0.88 times

Videos related to: 506235 announcements Alembic Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

506235 announcements Alembic Ltd. announcements and dividends declared BSE

 

Back to top